Related Experiment Video
Updated: Jul 3, 2026

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
Published on: December 27, 2024
Does age affect the response to zinc therapy for diarrhoea in Bangladeshi infants?
Christa L Fischer Walker1, Robert E Black, Abdullah H Baqui
1Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Room E5543, Baltimore, MD 21205, USA. cfischer@jhsph.edu
Insights
Zinc supplementation shows potential benefits in treating diarrhea in children. Further research is needed to confirm its effectiveness, especially in infants under six months old.
Area of Science:
- Pediatrics
- Nutritional Science
- Public Health
Background:
- Diarrhea remains a leading cause of mortality in children under five globally.
- Zinc supplementation has been established as an effective treatment for diarrhea in children.
- Previous studies reported the benefits of zinc for diarrhea treatment in Bangladeshi children aged 3-59 months.
Purpose of the Study:
- To investigate the age-specific benefits of zinc for diarrhea treatment.
- To analyze the impact of zinc on diarrhea duration, subsequent morbidity, and mortality across different age strata.
Main Methods:
- A cluster-randomized trial was conducted in rural Bangladesh.
- Children aged 3-59 months were included in the study.
- Data were stratified by age groups: 3-5 months, 6-11 months, and 12-59 months.
Main Results:
- Trends suggest potential benefits of zinc in reducing diarrhea duration and improving outcomes in all age groups.
- Statistical significance was not detected in the younger age strata (3-5 and 6-11 months) due to small sample sizes.
- The study highlights a possible positive effect of zinc on reducing subsequent morbidity and mortality.
Conclusions:
- Zinc supplementation may offer benefits for treating diarrhea in children across various age groups.
- Further research is required to establish the efficacy of zinc for diarrhea treatment in infants younger than six months.
- Age-specific research is crucial for optimizing zinc's role in pediatric diarrhea management.
Abstract:
The benefit of zinc for the treatment of diarrhoea in a cluster-randomized trial of children, aged 3-59 months, living in rural Bangladesh was previously reported. Here, the benefits of zinc stratified by age--3-5 months, 6-11 months, and 12-59 months--are reported. Although the sample sizes in the stratified groups were too small to detect statistical significance in the 3-5-month and 6-11-month age-groups, the trends suggest that there may be a benefit of zinc for the treatment of diarrhoea on the duration of diarrhoea and on subsequent morbidity and mortality. Additional research is needed to better understand the effect of zinc for the treatment of diarrhoea among infants aged less than six months.
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Factors Affecting Drug Response: Overview
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Pediatric Patients: Drug Excretion